Galaxy Medicare Limited (NSE:GML)
India · Delayed Price · Currency is INR 17.55
-0.30 (-1.68%)
At close: Jul 17, 2026
Galaxy Medicare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 400.03 | 392.02 | 361.51 | 312.05 | 298.78 |
Other Revenue | - | 0.5 | 1.13 | 0.25 | 0.61 |
| 400.03 | 392.52 | 362.63 | 312.31 | 299.38 | |
Revenue Growth (YoY) | 1.92% | 8.24% | 16.11% | 4.32% | 3.93% |
Cost of Revenue | 250.98 | 256.15 | 227.34 | 215.83 | 209.77 |
Gross Profit | 149.05 | 136.37 | 135.3 | 96.48 | 89.61 |
Selling, General & Admin | 54.85 | 46.17 | 38.98 | 32.46 | 28.72 |
Other Operating Expenses | 38.83 | 36.52 | 39.87 | 35.02 | 31.12 |
Operating Expenses | 99.21 | 87.68 | 83.66 | 78.64 | 69.67 |
Operating Income | 49.84 | 48.69 | 51.63 | 17.84 | 19.95 |
Interest Expense | -2.77 | -6.72 | -9.38 | -8.83 | -7.97 |
Interest & Investment Income | - | 1.94 | 0.61 | 1.39 | 0.24 |
Currency Exchange Gain (Loss) | - | 0.9 | 0.53 | 0.78 | 0.65 |
Other Non Operating Income (Expenses) | - | -0.68 | -0.03 | -0.68 | -0.87 |
EBT Excluding Unusual Items | 47.07 | 44.13 | 43.36 | 10.49 | 11.99 |
Gain (Loss) on Sale of Investments | - | 1.13 | 3.9 | 9.54 | -11.62 |
Gain (Loss) on Sale of Assets | - | - | - | -0.55 | -0.05 |
Other Unusual Items | - | 0.08 | - | 0.55 | 0.41 |
Pretax Income | 47.07 | 45.34 | 47.26 | 20.03 | 0.74 |
Income Tax Expense | 12.89 | 11.63 | 10.19 | 4.31 | 2.87 |
Net Income | 34.18 | 33.7 | 37.07 | 15.71 | -2.13 |
Net Income to Common | 34.18 | 33.7 | 37.07 | 15.71 | -2.13 |
Net Income Growth | 1.42% | -9.09% | 135.93% | - | - |
Shares Outstanding (Basic) | 15 | 12 | 12 | 12 | 12 |
Shares Outstanding (Diluted) | 15 | 12 | 12 | 12 | 12 |
Shares Change (YoY) | 28.05% | - | - | - | 8.57% |
EPS (Basic) | 2.25 | 2.84 | 3.12 | 1.32 | -0.18 |
EPS (Diluted) | 2.25 | 2.84 | 3.12 | 1.32 | -0.18 |
EPS Growth | -20.77% | -8.97% | 136.36% | - | - |
Free Cash Flow | 1.64 | 42.59 | 20.39 | 27.79 | -24.69 |
Free Cash Flow Per Share | 0.11 | 3.59 | 1.72 | 2.34 | -2.08 |
Dividend Per Share | 0.700 | 0.750 | 0.500 | 0.128 | 0.128 |
Dividend Growth | -6.67% | 50.00% | 290.02% | - | 100.00% |
Gross Margin | 37.26% | 34.74% | 37.31% | 30.89% | 29.93% |
Operating Margin | 12.46% | 12.40% | 14.24% | 5.71% | 6.66% |
Profit Margin | 8.54% | 8.59% | 10.22% | 5.03% | -0.71% |
Free Cash Flow Margin | 0.41% | 10.85% | 5.62% | 8.90% | -8.25% |
EBITDA | 55.37 | 53.69 | 56.44 | 28.97 | 29.75 |
EBITDA Margin | 13.84% | 13.68% | 15.56% | 9.28% | 9.94% |
D&A For EBITDA | 5.54 | 5 | 4.81 | 11.13 | 9.8 |
EBIT | 49.84 | 48.69 | 51.63 | 17.84 | 19.95 |
EBIT Margin | 12.46% | 12.40% | 14.24% | 5.71% | 6.66% |
Effective Tax Rate | 27.38% | 25.66% | 21.55% | 21.54% | 388.89% |
Revenue as Reported | 413.15 | 402.68 | 369.37 | 320.29 | 307.37 |